Clinical Trial Update: A Study of CNTO 3157 in Healthy Normal and Asthmatic Participants Inoculated With Human Rhinovirus Type 16 [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating CNTO 3157 in healthy volunteers and individuals with asthma after inoculation with rhinovirus type 16; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• CNTO 3157

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Healthy Volunteers and Asthma | Phase 1 | Status: COMPLETED